Skip to main content
OpenTrials

Clinical trial condition

Recurrent/Metastatic Endometrial Cancer

Explore clinical trials studying Recurrent/Metastatic Endometrial Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent/Metastatic Endometrial Cancer trial results

Not Yet Recruiting

Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial

NCT06771154

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences Beijing, China, Beijing Municipality, China
View Trial Details

Related conditions